10.1016/s1535-6108(03)00026-6
Crossref journal-article
Elsevier BV
Cancer Cell (78)
Bibliography

Blain, S. W., Scher, H. I., Cordon-Cardo, C., & Koff, A. (2003). p27 as a target for cancer therapeutics. Cancer Cell, 3(2), 111–115.

Authors 4
  1. Stacy W Blain (first)
  2. Howard I Scher (additional)
  3. Carlos Cordon-Cardo (additional)
  4. Andrew Koff (additional)
References 43 Referenced 122
  1. 10.1128/AAC.44.10.2794-2801.2000 / Antimicrob. Agents Chemother. / Inhibition of cyclin-dependent kinase activity and induction of apoptosis by preussin in human tumor cells by Achenbach (2000)
  2. 10.1172/JCI6443 / J. Clin. Invest. / Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells by Baldassarre (1999)
  3. 10.1182/blood.V98.5.1524 / Blood / Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27(kip1) by Barata (2001)
  4. 10.1038/sj.onc.1206163 / Oncogene / p27 deficiency desensitizes Rb−/− cells to signals that trigger apoptosis during pituitary tumor development by Carneiro (2002)
  5. {'key': '10.1016/S1535-6108(03)00026-6_BIB5', 'first-page': '97', 'article-title': 'Update on mechanisms of drug resistance', 'volume': '86', 'author': 'Chauffert', 'year': '1999', 'journal-title': 'Bull. Cancer'} / Bull. Cancer / Update on mechanisms of drug resistance by Chauffert (1999)
  6. 10.1016/S0002-9440(10)62571-0 / Am. J. Pathol. / S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase by Chiarle (2002)
  7. {'key': '10.1016/S1535-6108(03)00026-6_BIB7', 'first-page': '114', 'article-title': 'Localization and expression of p27Kip1 in multistage colorectal carcinogenesis', 'volume': '58', 'author': 'Ciaprrone', 'year': '1998', 'journal-title': 'Cancer Res.'} / Cancer Res. / Localization and expression of p27Kip1 in multistage colorectal carcinogenesis by Ciaprrone (1998)
  8. 10.1210/mend.15.6.0650 / Mol. Endocrinol. / Inhibin and p27 interact to regulate gonadal tumorigenesis by Cipriano (2001)
  9. 10.1093/jnci/90.17.1284 / J. Natl. Cancer Inst. / Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma by Cordon-Cardo (1998)
  10. 10.1101/gad.12.15.2434 / Genes Dev. / E1A signaling to p53 involves the p19ARF tumor suppressor by de Stanchina (1998)
  11. 10.1038/84879 / Nat. Genet. / Pten and p27 Kip1 cooperate in prostate cancer tumor suppression in the mouse by Di Cristofano (2001)
  12. 10.1016/S0092-8674(00)81239-8 / Cell / A syndrome of multi-organ hyperplasia with features of gigantism, tumorigenesis and female sterility in p27Kip1-deficient mice by Fero (1996)
  13. 10.1038/24179 / Nature / The murine gene p27Kip1 is haplo-insufficient for tumour suppression by Fero (1998)
  14. 10.1073/pnas.081474898 / Proc. Natl. Acad. Sci. USA / Skp2 is oncogenic and overexpressed in human cancers by Gstaiger (2001)
  15. 10.1002/1097-0142(20010501)91:9<1745::AID-CNCR1193>3.0.CO;2-H / Cancer / Inverse relation between levels of p27Kip1 and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas by Hershko (2001)
  16. 10.1006/gyno.2001.6376 / Gynecol. Oncol. / Expression and subcellular localization of the cyclin-dependent kinase inhibitor p27(KLp1) in epithelial ovarian cancer by Hurteau (2001)
  17. 10.1002/pros.10124 / Prostate / Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1) by Katner (2002)
  18. 10.1016/S0092-8674(00)81238-6 / Cell / Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27Kip1 by Kiyokawa (1996)
  19. {'key': '10.1016/S1535-6108(03)00026-6_BIB19', 'first-page': '7044', 'article-title': 'High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas', 'volume': '61', 'author': 'Kudo', 'year': '2001', 'journal-title': 'Cancer Res.'} / Cancer Res. / High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas by Kudo (2001)
  20. 10.1073/pnas.041475098 / Proc. Natl. Acad. Sci. USA / Role of the F-box protein Skp2 in lymphagenesis by Latres (2001)
  21. 10.1038/nm761 / Nat. Med. / PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest by Liang (2002)
  22. 10.1038/sj.onc.1203991 / Oncogene / Disruption of TGF-β growth inhibition by oncogenic ras is linked to p27Kip1 mislocalization by Liu (2000)
  23. 10.1016/S0002-9440(10)65277-7 / Am. J. Pathol. / p27Kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers by Lloyd (1999)
  24. 10.1016/S0960-9822(01)00065-3 / Curr. Biol. / PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2) by Mamillapalli (2001)
  25. 10.1093/emboj/cdf364 / EMBO J. / Loss of p27Kip1 but not p21Cip1 decreases survival and synergizes with MYC in murine lymphomagenesis by Marins (2002)
  26. 10.1016/S0092-8674(00)00121-5 / Cell / TGF-b signaling in growth control, cancer and heritable disease by Massagué (2000)
  27. 10.1016/S0092-8674(00)81237-4 / Cell / Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors by Nakayama (1996)
  28. 10.1006/bbrc.2001.4627 / Biochem. Biophys. Res. Commun. / Regulation of the cell cycle at the G1-S transition by proteolysis of cyclin E and p27Kip1 by Nakayama (2001)
  29. 10.1073/pnas.96.11.6382 / Proc. Natl. Acad. Sci. USA / p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice by Park (1999)
  30. 10.1006/excr.2000.5143 / Exp. Cell Res. / p27Kip1: Regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer by Philipp-Staheli (2001)
  31. 10.1016/S1535-6108(02)00054-5 / Cancer Cell / Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice by Philipp-Staheli (2002)
  32. 10.1016/S0304-3835(01)00528-6 / Cancer Lett. / Ras and Rho regulation of the cell cycle and oncogenesis by Pruitt (2001)
  33. {'key': '10.1016/S1535-6108(03)00026-6_BIB33', 'first-page': '3689', 'article-title': 'The Pezcoller lecture: cancer cell cycles revisited', 'volume': '60', 'author': 'Sherr', 'year': '2000', 'journal-title': 'Cancer Res.'} / Cancer Res. / The Pezcoller lecture: cancer cell cycles revisited by Sherr (2000)
  34. 10.1016/S1535-6108(02)00102-2 / Cancer Cell / The RB and p53 pathways in cancer by Sherr (2002)
  35. 10.1038/nm759 / Nat. Med. / Akt/PKB mediates cell cycle progression by phosphorylation of p27kip1 on threonine157 and modulation of its cellular localization by Shin (2002)
  36. {'key': '10.1016/S1535-6108(03)00026-6_BIB36', 'first-page': '1730', 'article-title': "Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma", 'volume': '58', 'author': 'Singh', 'year': '1998', 'journal-title': 'Cancer Res.'} / Cancer Res. / Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma by Singh (1998)
  37. 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I / J. Cell. Physiol. / Regulation of the cdk inhibitor p27 and its deregulation in cancer by Slingerland (2000)
  38. 10.1093/emboj/20.23.6637 / EMBO J. / Wide spectrum of tumors in knock-in mice carrying a cdk4 protein insensitive to Ink4 inhibitors by Sotillo (2001)
  39. 10.1038/nm1196-1204 / Nat. Med. / Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents by St Croix (1996)
  40. 10.1016/S1368-8375(02)00011-8 / Oral Oncol. / Overexpression of p27(Kip1) induces growth arrest and apoptosis in an oral cancer cell line by Supriatno (2002)
  41. 10.1146/annurev.med.50.1.401 / Annu. Rev. Med. / The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer by Tsihlias (1999)
  42. 10.1038/nm762 / Nat. Med. / Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer by Viglietto (2002)
  43. 10.1074/jbc.C000147200 / J. Biol. Chem. / Oncogenic signals of Her-2/neu in regulating the stability of the cyclin-dependent kinase inhibitor p27 by Yang (2000)
Dates
Type When
Created 21 years, 4 months ago (April 14, 2004, 5:27 a.m.)
Deposited 6 years, 6 months ago (Feb. 13, 2019, 9:53 p.m.)
Indexed 1 month ago (July 24, 2025, 7:33 a.m.)
Issued 22 years, 6 months ago (Feb. 1, 2003)
Published 22 years, 6 months ago (Feb. 1, 2003)
Published Print 22 years, 6 months ago (Feb. 1, 2003)
Funders 0

None

@article{Blain_2003, title={p27 as a target for cancer therapeutics}, volume={3}, ISSN={1535-6108}, url={http://dx.doi.org/10.1016/s1535-6108(03)00026-6}, DOI={10.1016/s1535-6108(03)00026-6}, number={2}, journal={Cancer Cell}, publisher={Elsevier BV}, author={Blain, Stacy W and Scher, Howard I and Cordon-Cardo, Carlos and Koff, Andrew}, year={2003}, month=feb, pages={111–115} }